• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏来自可溶性蛋白片段研究的证据表明 Knops 血型多态性在补体受体 1 中是由疟疾驱动的。

Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria.

机构信息

The Institute of Structural and Molecular Biology, University of Edinburgh, Edinburgh, United Kingdom.

出版信息

PLoS One. 2012;7(4):e34820. doi: 10.1371/journal.pone.0034820. Epub 2012 Apr 10.

DOI:10.1371/journal.pone.0034820
PMID:22506052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3323580/
Abstract

Complement receptor-type 1 (CR1, CD35) is the immune-adherence receptor, a complement regulator, and an erythroid receptor for Plasmodium falciparum during merozoite invasion and subsequent rosette formation involving parasitized and non-infected erythrocytes. The non-uniform geographical distribution of Knops blood group CR1 alleles Sl1/2 and McC(a/b) may result from selective pressures exerted by differential exposure to infectious hazards. Here, four variant short recombinant versions of CR1 were produced and analyzed, focusing on complement control protein modules (CCPs) 15-25 of its ectodomain. These eleven modules encompass a region (CCPs 15-17) key to rosetting, opsonin recognition and complement regulation, as well as the Knops blood group polymorphisms in CCPs 24-25. All four CR1 15-25 variants were monomeric and had similar axial ratios. Modules 21 and 22, despite their double-length inter-modular linker, did not lie side-by-side so as to stabilize a bent-back architecture that would facilitate cooperation between key functional modules and Knops blood group antigens. Indeed, the four CR1 15-25 variants had virtually indistinguishable affinities for immobilized complement fragments C3b (K(D) = 0.8-1.1 µM) and C4b (K(D) = 5.0-5.3 µM). They were all equally good co-factors for factor I-catalysed cleavage of C3b and C4b, and they bound equally within a narrow affinity range, to immobilized C1q. No differences between the variants were observed in assays for inhibition of erythrocyte invasion by P. falciparum or for rosette disruption. Neither differences in complement-regulatory functionality, nor interactions with P. falciparum proteins tested here, appear to have driven the non-uniform geographic distribution of these alleles.

摘要

补体受体 1 型(CR1,CD35)是免疫粘附受体、补体调节剂和疟原虫裂殖子入侵和随后涉及寄生和未感染红细胞的玫瑰花形成的红细胞受体。Knops 血型 CR1 等位基因 Sl1/2 和 McC(a/b) 的非均匀地理分布可能是由于对不同感染危害的选择性压力造成的。在这里,产生并分析了四个变异的短重组 CR1 版本,重点是其外域的补体控制蛋白模块(CCPs)15-25。这十一个模块包含一个关键的玫瑰花形成区域(CCPs 15-17)、调理素识别和补体调节,以及 CCPs 24-25 中的 Knops 血型多态性。所有四个 CR1 15-25 变体都是单体,具有相似的轴比。尽管模块 21 和 22 具有双长度的模块间接头,但它们并没有并排排列,从而稳定了一个弯曲的后向结构,这将有助于关键功能模块和 Knops 血型抗原之间的合作。事实上,四个 CR1 15-25 变体对固定化补体片段 C3b(K(D)=0.8-1.1 μM)和 C4b(K(D)=5.0-5.3 μM)的亲和力几乎无法区分。它们都是因子 I 催化切割 C3b 和 C4b 的同样良好的辅助因子,并且在狭窄的亲和力范围内,它们都与固定化 C1q 结合。在抑制疟原虫对红细胞的入侵或破坏玫瑰花的测定中,没有观察到变体之间的差异。在这里测试的补体调节功能的差异,以及与疟原虫蛋白的相互作用,似乎都没有导致这些等位基因的非均匀地理分布。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/42f854cdd6d0/pone.0034820.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/e78de99bb9c1/pone.0034820.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/c3454cd4ffc2/pone.0034820.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/5f6de2396bf7/pone.0034820.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/d29173963cc7/pone.0034820.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/ff88e76b244b/pone.0034820.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/d7c9b3e9e5b4/pone.0034820.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/f5ed30ae69e7/pone.0034820.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/db1144893fa9/pone.0034820.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/42f854cdd6d0/pone.0034820.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/e78de99bb9c1/pone.0034820.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/c3454cd4ffc2/pone.0034820.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/5f6de2396bf7/pone.0034820.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/d29173963cc7/pone.0034820.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/ff88e76b244b/pone.0034820.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/d7c9b3e9e5b4/pone.0034820.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/f5ed30ae69e7/pone.0034820.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/db1144893fa9/pone.0034820.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88f/3323580/42f854cdd6d0/pone.0034820.g009.jpg

相似文献

1
Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria.缺乏来自可溶性蛋白片段研究的证据表明 Knops 血型多态性在补体受体 1 中是由疟疾驱动的。
PLoS One. 2012;7(4):e34820. doi: 10.1371/journal.pone.0034820. Epub 2012 Apr 10.
2
Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.利用诱变和结构生物学绘制恶性疟原虫裂殖子蛋白 PfRh4 与人免疫黏附受体结合位点的图谱。
J Biol Chem. 2014 Jan 3;289(1):450-63. doi: 10.1074/jbc.M113.520346. Epub 2013 Nov 8.
3
CR1 Knops blood group alleles are not associated with severe malaria in the Gambia.CR1诺普斯血型等位基因与冈比亚的重症疟疾无关。
Genes Immun. 2003 Jul;4(5):368-73. doi: 10.1038/sj.gene.6363980.
4
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1.在补体受体1的长同源区域D中发现的诺普斯血型多态性的分子鉴定。
Blood. 2001 May 1;97(9):2879-85. doi: 10.1182/blood.v97.9.2879.
5
Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.恶性疟原虫利用补体受体 1 的关键功能部位入侵人红细胞。
Blood. 2011 Aug 18;118(7):1923-33. doi: 10.1182/blood-2011-03-341305. Epub 2011 Jun 17.
6
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.通过缺失诱变鉴定人C3b/C4b受体(CR1,CD35)中不同的C3b和C4b识别位点。
J Exp Med. 1988 Nov 1;168(5):1699-717. doi: 10.1084/jem.168.5.1699.
7
Role of CR1 Knops polymorphism in the pathophysiology of malaria: Indian scenario.CR1诺普斯多态性在疟疾病理生理学中的作用:印度情况
J Vector Borne Dis. 2009 Dec;46(4):288-94.
8
Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.锌离子抑制因子I介导的CR1结合免疫复合物的释放以及细胞结合补体因子C3b和C4b的降解。
Scand J Immunol. 1990 Apr;31(4):397-403. doi: 10.1111/j.1365-3083.1990.tb02785.x.
9
[The structure and role of CR1 complement receptor in physiology].[CR1补体受体在生理学中的结构与作用]
Pol Merkur Lekarski. 2010 Jan;28(163):79-83.
10
Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates.恶性疟原虫玫瑰花结形成所需补体受体(CR)1区域的定位及CR1在现场分离株玫瑰花结形成中的重要性证明
J Immunol. 2000 Dec 1;165(11):6341-6. doi: 10.4049/jimmunol.165.11.6341.

引用本文的文献

1
A novel and rapid method to purify the human complement opsonin C3b from human plasma.一种从人血浆中纯化人补体调理素C3b的新颖快速方法。
Front Immunol. 2025 Aug 26;16:1639735. doi: 10.3389/fimmu.2025.1639735. eCollection 2025.
2
variants contribute to FSGS susceptibility across multiple populations.多种变异在多个群体中导致局灶节段性肾小球硬化易感性。
iScience. 2025 Mar 18;28(4):112234. doi: 10.1016/j.isci.2025.112234. eCollection 2025 Apr 18.
3
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways.

本文引用的文献

1
, a program for rapid shape determination in small-angle scattering.用于小角散射中快速形状测定的一个程序。
J Appl Crystallogr. 2009 Apr 1;42(Pt 2):342-346. doi: 10.1107/S0021889809000338. Epub 2009 Jan 24.
2
Global malaria mortality between 1980 and 2010: a systematic analysis.全球疟疾死亡率 1980 年至 2010 年:系统分析。
Lancet. 2012 Feb 4;379(9814):413-31. doi: 10.1016/S0140-6736(12)60034-8.
3
Complement receptor 1 and malaria.补体受体 1 与疟疾。
三融合蛋白(TriFu):一种对所有三种补体激活途径均有效的、靶向性的、类似酶的抑制剂。
J Biol Chem. 2024 Apr;300(4):105784. doi: 10.1016/j.jbc.2024.105784. Epub 2024 Feb 23.
4
variants contribute to FSGS susceptibility across multiple populations.多种变异体在多个群体中导致局灶节段性肾小球硬化易感性。
medRxiv. 2023 Nov 20:2023.11.20.23298462. doi: 10.1101/2023.11.20.23298462.
5
Elucidation of the low-expressing erythroid CR1 phenotype by bioinformatic mining of the GATA1-driven blood-group regulome.通过生物信息挖掘 GATA1 驱动的血型调控组阐明低表达红细胞 CR1 表型。
Nat Commun. 2023 Aug 17;14(1):5001. doi: 10.1038/s41467-023-40708-w.
6
Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in rosetting.再探玫瑰花结现象:对红细胞受体参与玫瑰花结形成的证据的批判性观察
Parasitology. 2020 Jan;147(1):1-11. doi: 10.1017/S0031182019001288. Epub 2019 Sep 16.
7
Two complement receptor one alleles have opposing associations with cerebral malaria and interact with αthalassaemia.两个补体受体 1 等位基因与脑型疟疾呈相反关联,并与α地中海贫血相互作用。
Elife. 2018 Apr 25;7:e31579. doi: 10.7554/eLife.31579.
8
C1q and Mannose-Binding Lectin Interact with CR1 in the Same Region on CCP24-25 Modules.C1q 和甘露聚糖结合凝集素与 CR1 在 CCP24-25 模块上的相同区域相互作用。
Front Immunol. 2018 Mar 7;9:453. doi: 10.3389/fimmu.2018.00453. eCollection 2018.
9
No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.没有证据表明 Knops 血型多态性影响红细胞上补体受体 1 的聚集。
Sci Rep. 2017 Dec 19;7(1):17825. doi: 10.1038/s41598-017-17664-9.
10
Protection of host cells by complement regulators.补体调节蛋白对宿主细胞的保护作用。
Immunol Rev. 2016 Nov;274(1):152-171. doi: 10.1111/imr.12475.
Cell Microbiol. 2011 Oct;13(10):1441-50. doi: 10.1111/j.1462-5822.2011.01648.x. Epub 2011 Aug 24.
4
Structural basis for complement factor I control and its disease-associated sequence polymorphisms.补体因子 I 调控及其与疾病相关序列多态性的结构基础。
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12839-44. doi: 10.1073/pnas.1102167108. Epub 2011 Jul 18.
5
Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.恶性疟原虫利用补体受体 1 的关键功能部位入侵人红细胞。
Blood. 2011 Aug 18;118(7):1923-33. doi: 10.1182/blood-2011-03-341305. Epub 2011 Jun 17.
6
Knops blood group polymorphism and susceptibility to Mycobacterium tuberculosis infection.克诺斯血型多态性与结核分枝杆菌感染易感性。
Transfusion. 2011 Nov;51(11):2462-9. doi: 10.1111/j.1537-2995.2011.03161.x. Epub 2011 May 13.
7
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.用重组 PfEMP1 结构域免疫可诱导针对恶性疟原虫的功能性红细胞花环抑制和吞噬诱导抗体。
PLoS One. 2011 Jan 31;6(1):e16414. doi: 10.1371/journal.pone.0016414.
8
Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes.恶性疟原虫野外分离株利用补体受体1(CR1)作为侵入红细胞的受体。
Mol Biochem Parasitol. 2011 May;177(1):57-60. doi: 10.1016/j.molbiopara.2011.01.005. Epub 2011 Jan 18.
9
Production of biologically active complement factor H in therapeutically useful quantities.以治疗有效量生产生物活性补体因子H。
Protein Expr Purif. 2011 Apr;76(2):254-63. doi: 10.1016/j.pep.2010.12.002. Epub 2010 Dec 10.
10
Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand.补体受体 1 是恶性疟原虫 PfRh4 入侵配体的宿主红细胞受体。
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17327-32. doi: 10.1073/pnas.1008151107. Epub 2010 Sep 20.